Celgene Officially Notified Of ANDA Filing For REVLIMID
Celgene Corporation (NASDAQ: CELG) announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application...
View ArticlePrecious Cat Inc., Multiple Myeloma Research Foundation (MMRF) Join Forces To...
Precious Cat and the Multiple Myeloma Research Foundation (MMRF) announced a new partnership to accelerate the development of new treatments for multiple myeloma, an incurable blood cancer. During the...
View ArticleThe International Myeloma Foundation Says Major Medical Meeting In Paris Will...
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said the 13th Annual International Myeloma Workshop in...
View ArticleGELA, The Premier Cooperative Group In Adult Lymphoma Research Choses...
Groupe d’Etude des Lymphomes de l’Adulte (GELA) and Celgene International Sarl (Nasdaq: CELG) today announced a collaboration to conduct an international randomized study to evaluate the therapeutic...
View Article
